Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis

被引：2
|
作者：
Groen, Kira [1 ,2 ]
Lechner-Scott, Jeannette [1 ,2 ]
Pohl, Daniela [3 ]
Levy, Michael [4 ]
Giovannoni, Gavin [5 ]
Hawkes, Chris [6 ]
机构：
[1] Univ Newcastle, Hunter Med Researc Inst, Newcastle, NSW, Australia
[2] Hunter New England Area Hlth, Newcastle, NSW, Australia
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Harvard Univ, Cambridge, MA 02138 USA
[5] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Dept Neurol, London, England
[6] Queen Mary Univ London, Dept Neurol, Neurosci Ctr, London, England
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2021年 / 50卷
关键词：
WHITE-MATTER LESIONS; NEUROMYELITIS-OPTICA; SPECTRUM;
D O I：
10.1016/j.msard.2021.102931
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Progressive Multiple Sclerosis Biomarkers: Plasma Neurofilament Light Chain and Glial Fibrillary Acidic Protein Levels are Elevated and Correlated
    Schorr, Emily M.
    Gill, Alexander J.
    Smith, Matthew D.
    Valenzuela, Alyssandra
    Thero, Rachel
    Duval, Anna L.
    Winger, Ryan C.
    Graziano, Jasmin
    Harp, Christopher
    Lewis, Alexandria
    Lord, Hannah-Noelle
    Siu, Catherine
    Resto, Yasmin
    Deslauriers, Annaelle
    Bhargava, Pavan
    Saidha, Shiv
    Sotirchos, Elias
    Mowry, Ellen M.
    Calabresi, Peter A.
    Fitzgerald, Kathryn C.
    ANNALS OF NEUROLOGY, 2022, 92 : S146 - S147
  • [42] Specificity of glial fibrillary acidic protein IgG autoantibody (GFAP-IgG) for Autoimmune Meningoencephalomyelitis Diagnosis
    Flanagan, Eoin
    Dubey, Divyanshu
    Hinson, Shannon
    Lennon, Vanda
    Fang, Boyan
    Aksamit, Allen
    Weinshenker, Brian
    Pittock, Sean
    McKeon, Andrew
    NEUROLOGY, 2017, 88
  • [43] Plasma glial fibrillary acidic protein correlates with characteristics of advanced disease and treatment response in secondary progressive multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Meinert, R.
    Maceski, A. M.
    Dahlke, F.
    Hach, T.
    Tomic, D.
    Kappos, L.
    Leppert, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 916 - 916
  • [44] Plasma neurofilament light chain and glial fibrillary acidic protein levels correlate and are elevated in people with progressive multiple sclerosis
    Schorr, E. M.
    Gill, A. J.
    Smith, M. D.
    Valenzuela, A.
    Thero, R.
    Duval, A. L.
    Winger, R. C.
    Graziano, J.
    Harp, C.
    Lewis, A.
    Lord, H-N
    Siu, C.
    Resto, Y.
    Deslauriers, A.
    Bhargava, P.
    Saidha, S.
    Sotirchos, E.
    Mowry, E. M.
    Calabresi, P. A.
    Fitzgerald, K. C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 825 - 826
  • [45] EXPRESSION OF GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) BY CULTURED ANGIOFIBROMA STROMA CELLS FROM PATIENTS WITH TUBEROUS SCLEROSIS
    KATO, M
    KATSUMOTO, T
    OHNO, K
    KATOS, S
    HERZ, F
    TAKESHITA, K
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1992, 18 (06) : 559 - 565
  • [46] Glial fibrillary acidic protein and neurofilament light chain as biomarkers in pediatric multiple sclerosis
    Saucier, Laura
    Healy, Brian C.
    Saxena, Shrishti
    Sanon, Eunnindy
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (03)
  • [47] Serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) as potential biomarkers for disease activity and disability in neuromyelitis optica spectrum disorders and multiple sclerosis
    Watanabe, Mitsuru
    Nakamura, Yuri
    Michalak, Zuzanna
    Hayashi, Fumie
    Barro, Christian
    Isobe, Noriko
    Matsushita, Takuya
    Yamasaki, Ryo
    Kuhle, Jens
    Kira, Jun-ichi
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 438 - 439
  • [48] Serum neurofilament light chain (NfL)and CSF glial fibrillary acidic protein (GFAP) together improve the prediction of long-term clinical outcomes in multiple sclerosis
    Thebault, Simon
    Fereshtehnejad, Seyed Mohammad
    Bergman, Hailey
    Bose, Gauruv
    Freedman, Mark
    NEUROLOGY, 2023, 100 (17)
  • [49] Serum Neurofilament Light Chain (NfL) and CSF Glial Fibrillary Acidic Protein (GFAP) Together Improve the Prediction of Long-Term Clinical Progression in Multiple Sclerosis
    Thebault, S.
    Bose, G.
    Fereshtehnejad, S.
    Bergman, H.
    Booth, R. A.
    Freedman, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 37 - 37
  • [50] Glial fibrillary acidic protein (GFAP) and S100B protein serum levels in recent onset schizophrenia
    Fekkes, D.
    van Beveren, N. J. M.
    Roder, C. H. R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S505 - S506
12345